Plain-English translation of NCT06001255 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 clinical trial testing a medication called to treat advanced cancers, particularly metastatic castration-resistant prostate cancer and other solid tumors that have stopped responding to standard therapies. Researchers will give the medication intravenously and carefully track how well it works, how safe it is, and how your body processes it.
People with advanced cancers often run out of treatment options when standard therapies stop working or cause unbearable side effects. This trial exists to see whether this new medication could offer hope to patients in that situation.
You would receive intravenous infusions of the medication at a dose calculated based on your body weight. You would visit the study center regularly for treatment sessions and to have your cancer monitored through scans and blood tests. The study will carefully watch you for side effects during treatment and for 90 days after your last dose. If the medication works well and you tolerate it, you may be able to continue receiving it as long as there is clinical benefit.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
China